Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and effectiveness of 2 treatments for
thrush (a fungal infection of the mouth and throat) in HIV-positive patients. Fluconazole is
a drug that is commonly used to treat thrush. SCH 56592 is a new drug that will be compared
to fluconazole.